- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01354249
Preoperative Feeding With a Whey Protein Plus Carbohydrate Drink on the Acute Phase Response and Insulin Resistance
Effects of Preoperative Feeding With a Whey Protein Plus Carbohydrate Drink on the Acute Phase Response and Insulin Resistance.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The patients will be randomized into two groups: the carbohydrate-protein group (CHO-P) and the control group (CO). The patients will reeive a specific drink to their group on the evening prior to surgery and three hours before the operation. The CHO-P group will receive 474 ml (evening drink) or 237 ml (3h prior to operation drink) of a solution containing 14% whey protein (100% lactoalbumin), 86% carbohydrates (45% hydrolyzed corn starch and 55% sucrose) and 0% lipids (Resource® Breeze - Nestlé, São Paulo, Brasil) and the CO group will receive the same volume of water.
Outcome measures On the day of the surgery and on the first postoperative day blood samples will be collected for glucose, insulin, triglycerides, albumin, pre-albumin, CRP, and α-1-acid glycoprotein (α-1-GA) assays. HOMA-IR will be calculated
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Mato Grosso
-
Cuiaba, Mato Grosso, Brazil, 78000-000
- Hospital Julio Muller
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults (18-65 years-old)
- Both sexes
- Candidates to elective moderate operations such as open cholecystectomy, laparoscopic cholecystectomy and unilateral repair of inguinal hernia).
Exclusion Criteria:
- Acute cholecystitis
- Diabetes mellitus
- Chronic kidney failure
- Chronic liver disease ot serum bilirubin greater than 2 mg/dL, body mass index (BMI) above 35Kg/m2
- American Anesthesiologists Association (ASA) score above 2
- Gastro-esophageal reflux
- Gastroparesis or intestinal obstruction
- Patients with any non-compliance with the study protocol, or who had associated operations, or presented significant intraoperative occurrences, or experienced prolonged operations (lasting more than 3 hours) were also excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: water
Patients will receive water 3h before operation in the same volume of the study group
|
The CHO-P group received 474 ml (evening drink) or 237 ml (3h prior to operation drink) of a solution containing 14% whey protein (100% lactoalbumin), 86% carbohydrates (45% hydrolyzed corn starch and 55% sucrose) and 0% lipids (Resource® Breeze - Nestlé, São Paulo, Brasil)
Other Names:
|
Experimental: whey protein plus carbohydrate
The CHO-P group will receive 474 ml (evening drink) or 237 ml (3h prior to operation drink) of a solution containing 14% whey protein (100% lactoalbumin), 86% carbohydrates (45% hydrolyzed corn starch and 55% sucrose) and 0% lipids (Resource® Breeze - Nestlé, São Paulo, Brasil)
|
The CHO-P group received 474 ml (evening drink) or 237 ml (3h prior to operation drink) of a solution containing 14% whey protein (100% lactoalbumin), 86% carbohydrates (45% hydrolyzed corn starch and 55% sucrose) and 0% lipids (Resource® Breeze - Nestlé, São Paulo, Brasil)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
insulin resistance
Time Frame: Homa-IR will be assessed in two time points: baseline (2-3 h before operatio) and 24h after operation
|
Insulin resistance will be assessed by Homa-IR
|
Homa-IR will be assessed in two time points: baseline (2-3 h before operatio) and 24h after operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
acute-phase response
Time Frame: Assays for the various acute-phase proteins will be done 2-3h before operation and 24 h after the operation
|
Assays for albumin, pre-albumin, C reactive protein and α-1-acid glycoprotein
|
Assays for the various acute-phase proteins will be done 2-3h before operation and 24 h after the operation
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jose Aguilar-Nascimento, D, PhD, Federal University of Mato Grosso
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- fperrone
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Resistance
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedEndoplasmic Reticulum Stress | HIV Related Insulin Resistance | Protease Inhibitor Related Insulin ResistanceUnited States
-
Paloma Almeda-ValdésCompleted
-
German Diabetes CenterYale UniversityRecruiting
-
National Institute of Diabetes and Digestive and...Active, not recruitingSevere Insulin ResistanceUnited States
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Assiut UniversityCompleted
-
National Taiwan UniversityNational Cheng-Kung University HospitalCompletedExercise, Insulin Resistance, Visceral Adipose TissueTaiwan
-
The University of Texas Medical Branch, GalvestonCompletedInsulin Resistance, DiabetesUnited States
-
University Health Network, TorontoCompletedInsulin Resistance, DiabetesCanada
-
University Health Network, TorontoCompletedInsulin Resistance Syndrome X | Pancreatic Beta Cell FunctionCanada
Clinical Trials on whey protein plus carbohydrate drink
-
Federal University of Mato GrossoCompletedResidual Gastric Volume After the Ingestion of a Beverage Containing Carbohydrates Plus Whey ProteinGastritis | Peptic UlcerBrazil
-
Franco CarliCompleted
-
Meir Medical CenterCompleted
-
Johns Hopkins UniversityNational Institute on Aging (NIA); American College of Rheumatology Research...TerminatedRheumatoid ArthritisUnited States
-
Loughborough UniversityCompletedActive Population
-
Bispebjerg HospitalUniversity of Copenhagen; Arla FoodsCompleted
-
Universidade Estadual de LondrinaConselho Nacional de Desenvolvimento Científico e Tecnológico; Rousselot BVBA; Coordination for the Improvement of Higher Education PersonnelCompletedSarcopenia | Collagen DegenerationBrazil
-
Syracuse UniversityDairy Research InstituteCompletedBlood PressureUnited States
-
Jessica GrayUnknownPostoperative Complications | Postoperative Pain | Sleep | Satisfaction | Postoperative NauseaCanada
-
Coombe Women and Infants University HospitalRecruitingFasting | Glucose, Low Blood | Cesarean Delivery Affecting FetusIreland